Latest NAV & returns of TATA ASSET MANAGEMENT LTD.

Tata India Pharma & Healthcare Fund Direct Growth

Add To Compare

NAV on March 06, 2026
Category Equity:
Sector - Healthcare
Investment StyleBox
Mid Growth
Total Assets 1,240 cr
Turnover Ratio 11.18%
Expense Ratio 0.71%
Exit Load 0.25%if redeemed within
30 Days
0.00%if redeemed after 30 Days
Returns
  • 1M: 3.04%
  • 1Y: 8.99%
  • 3M: -2.77%
  • 3Y: 25.43%
  • 6M: -2.71%
  • 5Y: 17.08%
Min Investment 5,000
ADDITIONAL INFO
Fund Manager Rajat Srivastava (Since over 1 year)
ISIN INF277K019A3
Fund Family Tata
P/E Ratio 41.36
P/B Ratio 6.57
Launch Date December 28, 2015
Benchmark Nifty Pharma TR INR
ASSET ALLOCATION
EQUITY DISTRIBUTION
RISK MEASURES (3 yrs)
vs Nifty Pharma TR INR

Alpha 1.00
Beta 0.95
R-Squared 94.78
Info Ratio 0.04
Tracking Err 3.78
Sortino 2.036
Sharpe 1.129
Std Dev 16.162
Risk -
SECTOR WEIGHTINGS (%)
Financial 0.0%
Industrial 0.0%
Technology 0.0%
Basic Materials 3.38%
Consumer Cyclical 0.0%
Utilities Services 0.0%
Healthcare Services 96.62%
Energy Services 0.00%
Communication Services 0.00%
Consumer Defensive 0.00%
Real Estate 0.00%
INVESTMENT OBJECTIVE

The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.

You will not receive any dividends. Your investments will get the largest benefit of compounding.

View Factsheet

-
Best Sector Healthcare Funds
NAME LATEST
NAV
RETURNS
1y    
FUND
ASSETS
Expense
RATIO
RISK
43.966 14.21% 2,640 cr 0.48% -
318.019 9.58% 1,055 cr 1.3% -
41.110 8.90% 6,658 cr 1.02% -
494.072 8.52% 3,823 cr 0.92% -


Other plans of Tata India Pharma & Healthcare


Other Equity funds by Tata